Healthcare · Drug Manufacturers - Specialty & Generic
Aurobindo Pharma Ltd.
AUROPHARMA
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Key metrics
Market Cap
₹78,373 cr
P/E Ratio
22.47x
P/B Ratio
2.4x
ROE
10.68%
ROCE
13.46%
Debt / Equity
0.25x
Net Margin
11.11%
Dividend Yield
30%
EPS
₹59.81
Period
FY2025